We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Japara Healthcare Limited is a medical care facilities business based in Australia. Japara Healthcare shares (JHC) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Japara Healthcare has a trailing 12-month revenue of around $419.5 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.35 - $1.4 |
|---|---|
| 50-day moving average | $1.3804 |
| 200-day moving average | $1.1252 |
| Target price | $1.07 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.053 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.38
| 1 week (2021-09-17) | -0.72% |
|---|---|
| 1 month (2021-08-25) | 0.36% |
| 3 months (2021-06-25) | 6.98% |
| 6 months (2021-03-25) | 84.00% |
| 1 year (2020-09-25) | 294.29% |
|---|---|
| 2 years (2019-09-25) | 15.48% |
| 3 years (2018-09-25) | 1.47% |
| 5 years (2016-09-23) | -34.29% |
Valuing Japara Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Japara Healthcare 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Japara Healthcare 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.4 million (£0.0 million).
The EBITDA is a measure of a Japara Healthcare 's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $419.5 million |
|---|---|
| Gross profit TTM | $53.7 million |
| Return on assets TTM | -1.44% |
| Return on equity TTM | -6.5% |
| Profit margin | -3.36% |
| Book value | 0.789 |
| Market capitalisation | $368.8 million |
TTM: trailing 12 months
We're not expecting Japara Healthcare to pay a dividend over the next 12 months.
Over the last 12 months, Japara Healthcare 's shares have ranged in value from as little as $0.35 up to $1.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Japara Healthcare 's is 2.309. This would suggest that Japara Healthcare 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Japara Healthcare Limited, together with its subsidiaries, owns, develops, and operates residential aged care homes in Australia. It operates approximately 4,000 resident places across 50 homes, which include 33 homes in Victoria, seven homes in New South Wales, three homes in Queensland, five homes in South Australia, and two homes in Tasmania; and 180 independent living units across 5 retirement villages. The company was founded in 2005 and is based in Southbank, Australia.
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
We look at some of the biggest and best performing iron ore stocks in Australia.
Shares in the major banks have risen more than 50% in the last 12 months.
Steps to owning and managing China Evergrande Group shares from Australia.
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
